Literature DB >> 29353603

Oral fexinidazole for human African trypanosomiasis.

François Chappuis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29353603     DOI： 10.1016/S0140-6736(18)30019-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.

Authors:  Kelly A Bachovchin; Amrita Sharma; Seema Bag; Dana M Klug; Katherine M Schneider; Baljinder Singh; Hitesh B Jalani; Melissa J Buskes; Naimee Mehta; Scott Tanghe; Jeremiah D Momper; Richard J Sciotti; Ana Rodriguez; Kojo Mensa-Wilmot; Michael P Pollastri; Lori Ferrins
Journal:  J Med Chem       Date:  2019-01-10       Impact factor: 7.446

Review 2.  Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole.

Authors:  Philippe Neau; Heinz Hänel; Valérie Lameyre; Nathalie Strub-Wourgaft; Luc Kuykens
Journal:  Trop Med Infect Dis       Date:  2020-01-27

3.  Assembling Pharma Resources to Tackle Diseases of Underserved Populations.

Authors:  Dale J Kempf; Kennan C Marsh
Journal:  ACS Med Chem Lett       Date:  2020-03-27       Impact factor: 4.345

4.  Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity.

Authors:  Cyril Fersing; Louise Basmaciyan; Clotilde Boudot; Julien Pedron; Sébastien Hutter; Anita Cohen; Caroline Castera-Ducros; Nicolas Primas; Michèle Laget; Magali Casanova; Sandra Bourgeade-Delmas; Mélanie Piednoel; Alix Sournia-Saquet; Valère Belle Mbou; Bertrand Courtioux; Élisa Boutet-Robinet; Marc Since; Rachel Milne; Susan Wyllie; Alan H Fairlamb; Alexis Valentin; Pascal Rathelot; Pierre Verhaeghe; Patrice Vanelle; Nadine Azas
Journal:  ACS Med Chem Lett       Date:  2018-12-19       Impact factor: 4.345

5.  The Alkaloid-Enriched Fraction of Pachysandra terminalis (Buxaceae) Shows Prominent Activity against Trypanosoma brucei rhodesiense.

Authors:  Dagmar Flittner; Marcel Kaiser; Pascal Mäser; Norberto P Lopes; Thomas J Schmidt
Journal:  Molecules       Date:  2021-01-23       Impact factor: 4.411

6.  FRET Flow Cytometry-Based High Throughput Screening Assay To Identify Disrupters of Glucose Levels in Trypanosoma brucei.

Authors:  Charles M Voyton; Meredith T Morris; P Christine Ackroyd; James C Morris; Kenneth A Christensen
Journal:  ACS Infect Dis       Date:  2018-05-14       Impact factor: 5.084

7.  Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.

Authors:  Erofili Giannakopoulou; Vasiliki Pardali; Efseveia Frakolaki; Vasileios Siozos; Vassilios Myrianthopoulos; Emmanuel Mikros; Martin C Taylor; John M Kelly; Niki Vassilaki; Grigoris Zoidis
Journal:  Medchemcomm       Date:  2019-05-16       Impact factor: 3.597

8.  The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.

Authors:  Eric Pelfrene; Martin Harvey Allchurch; Nsengi Ntamabyaliro; Victoria Nambasa; Fátima V Ventura; Nithyanandan Nagercoil; Marco Cavaleri
Journal:  PLoS Negl Trop Dis       Date:  2019-06-27

9.  Salvia officinalis L.: Antitrypanosomal Activity and Active Constituents against Trypanosoma brucei rhodesiense.

Authors:  Núria Llurba Montesino; Marcel Kaiser; Pascal Mäser; Thomas J Schmidt
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

Review 10.  The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.

Authors:  Harry P De Koning
Journal:  Trop Med Infect Dis       Date:  2020-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.